• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19:β-地中海贫血患者已接种疫苗?

COVID-19: beta-thalassemia subjects immunised?

机构信息

Henry Warembourg Medicine School, Lille University, 59000 Lille, France.

NexGen Analytics, 82801 Sheridan, WY, United States.

出版信息

Med Hypotheses. 2020 Sep;142:109827. doi: 10.1016/j.mehy.2020.109827. Epub 2020 May 12.

DOI:10.1016/j.mehy.2020.109827
PMID:32447232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7217120/
Abstract

The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research.

摘要

新型冠状病毒肺炎(COVID-19)是一种传染性急性呼吸道传染病,其病原体已被证明是冠状病毒家族的一种新型病毒,即 SARS-CoV-2。最近的一项预印本研究表明,COVID19 对血红蛋白的 1-β 链进行了血红素攻击。β-地中海贫血症是由于血红蛋白β-链合成的默认而导致的。全球有 1.5%的人口是这种疾病的杂合子。在这项研究中,我们通过多元线性回归分析了 COVID-19 在意大利三个地区(普利亚、撒丁岛、西西里岛)的感染情况,这三个地区的β-地中海贫血患病率不同,以寻找一种联系。结果表明,β-地中海贫血症杂合子人群的患病率与 COVID-19 的免疫力呈负相关,这是通过回归分析得出的。本文仅供学术讨论,假设和结论需要通过进一步研究来证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6427/7217120/fd5b62929862/fx3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6427/7217120/fd5b62929862/fx3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6427/7217120/fd5b62929862/fx3_lrg.jpg

相似文献

1
COVID-19: beta-thalassemia subjects immunised?COVID-19:β-地中海贫血患者已接种疫苗?
Med Hypotheses. 2020 Sep;142:109827. doi: 10.1016/j.mehy.2020.109827. Epub 2020 May 12.
2
Beta-thalassemia may protect against COVID 19.β地中海贫血可能对新型冠状病毒肺炎有防护作用。
Med Hypotheses. 2020 Oct;143:110014. doi: 10.1016/j.mehy.2020.110014. Epub 2020 Jun 28.
3
SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.β地中海贫血患者的新型冠状病毒2型感染:来自意大利经验的初步数据。
Am J Hematol. 2020 Aug;95(8):E198-E199. doi: 10.1002/ajh.25840. Epub 2020 May 6.
4
COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.一名重型β地中海贫血合并重度肺动脉高压患者的新型冠状病毒肺炎
Hemoglobin. 2020 May;44(3):218-220. doi: 10.1080/03630269.2020.1779082. Epub 2020 Jun 18.
5
Prevalence and severity of Coronavirus disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β-thalassemia patients and effects of associated comorbidities: an Iranian nationwide study.输血依赖型和非输血依赖型β地中海贫血患者中2019冠状病毒病(COVID-19)的患病率、严重程度及相关合并症的影响:一项伊朗全国性研究
Acta Biomed. 2020 Sep 7;91(3):e2020007. doi: 10.23750/abm.v91i3.10155.
6
Thalassemic Child Presenting with Anosmia due to COVID-19.一名因新冠病毒感染而嗅觉丧失的地中海贫血患儿。
Indian J Pediatr. 2020 Sep;87(9):750. doi: 10.1007/s12098-020-03370-4. Epub 2020 Jun 9.
7
COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.新冠病毒肺炎作为一名成年镰状细胞病患者急性胸综合征的病因
Am J Hematol. 2020 Jul;95(7):E154-E156. doi: 10.1002/ajh.25809. Epub 2020 Apr 21.
8
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.意大利米兰都会区儿童在新冠疫情期间出现冻疮样肢端病变疫情。
J Am Acad Dermatol. 2020 Sep;83(3):965-969. doi: 10.1016/j.jaad.2020.06.019. Epub 2020 Jun 10.
9
COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.新型冠状病毒肺炎脑病:脑脊液中抗严重急性呼吸综合征冠状病毒2抗体的检测
J Neurol. 2020 Oct;267(10):2810-2811. doi: 10.1007/s00415-020-09975-1. Epub 2020 Jun 11.
10
COVID-19 Severity Correlates with Weaker T-Cell Immunity, Hypercytokinemia, and Lung Epithelium Injury.新冠病毒疾病的严重程度与较弱的T细胞免疫、高细胞因子血症以及肺上皮损伤相关。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):606-610. doi: 10.1164/rccm.202005-1701LE.

引用本文的文献

1
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G.一项综述主要遗传因素对撒丁岛 COVID-19 病程的影响:人类白细胞抗原-G 的作用。
Front Immunol. 2023 Jun 5;14:1138559. doi: 10.3389/fimmu.2023.1138559. eCollection 2023.
2
Non-pulmonary involvement in COVID-19: A systemic disease rather than a pure respiratory infection.新型冠状病毒肺炎的肺外表现:一种全身性疾病而非单纯的呼吸道感染。
World J Clin Cases. 2023 Jan 26;11(3):493-505. doi: 10.12998/wjcc.v11.i3.493.
3
Haematology audit of 801 COVID-19 patients' basics and beyond- Prospective observational study.

本文引用的文献

1
HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia.2019新型冠状病毒肺炎典型输入性病例的高分辨率CT成像特征
Precis Clin Med. 2020 Mar;3(1):9-13. doi: 10.1093/pcmedi/pbaa004. Epub 2020 Feb 11.
2
Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.COVID-19 患者中的肺栓塞:是时候改变 CT 检查模式了。
Thromb Res. 2020 Jun;190:58-59. doi: 10.1016/j.thromres.2020.04.011. Epub 2020 Apr 11.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
对801例新冠病毒肺炎患者的基础及其他方面进行血液学审核——前瞻性观察研究。
J Family Med Prim Care. 2022 Aug;11(8):4460-4466. doi: 10.4103/jfmpc.jfmpc_44_22. Epub 2022 Aug 30.
4
The beneficial role of Hepcidin peptide inhibitor in improved the symptoms of COVID-19 in diabetics: anti-inflammatory and potential therapeutic effects.铁调素肽抑制剂在改善糖尿病患者COVID-19症状方面的有益作用:抗炎和潜在治疗效果。
J Diabetes Metab Disord. 2022 Jul 6;21(2):1797-1807. doi: 10.1007/s40200-022-01053-9. eCollection 2022 Dec.
5
Pattern of molecular mimicry between spike protein of SARS CoV2 and human thrombopoietin in beta, delta and omicron variants: a basic pathophysiological process of COVID-19 related thrombocytopenia.SARS-CoV-2刺突蛋白与人类血小板生成素在β、δ和奥密克戎变体中的分子模拟模式:COVID-19相关血小板减少症的基本病理生理过程
Am J Blood Res. 2022 Apr 15;12(2):60-63. eCollection 2022.
6
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry.地中海贫血症与 COVID-19 住院并发症和死亡率降低呈矛盾相关:来自国际登记处的数据。
J Cell Mol Med. 2022 May;26(9):2520-2528. doi: 10.1111/jcmm.17026. Epub 2022 Mar 30.
7
COVID-19 in Patients with Transfusion Dependent Thalassemia (TDT) in Indonesia: Characteristics of the Disease and Patients, and Comparison between Epidemiological Data for COVID-19 and Thalassemia in Indonesia and Southeast Asia.印度尼西亚依赖输血的地中海贫血(TDT)患者中的新冠病毒疾病(COVID-19):疾病和患者特征,以及印度尼西亚和东南亚COVID-19与地中海贫血流行病学数据的比较
Hematol Rep. 2022 Feb 23;14(1):2-12. doi: 10.3390/hematolrep14010002.
8
Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients.危重症COVID-19患者氧合血红蛋白解离曲线的时间变化
J Clin Med. 2022 Jan 31;11(3):788. doi: 10.3390/jcm11030788.
9
COVID-19: A pluralistic and integrated approach for efficient management of the pandemic.新冠疫情:一种高效管理该大流行病的多元综合方法。
World J Virol. 2022 Jan 25;11(1):20-39. doi: 10.5501/wjv.v11.i1.20.
10
From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies.从 H1N1 到 COVID-19:我们在患有血红蛋白病的儿童中看到的情况。
Clinics (Sao Paulo). 2022 Jan 29;77:100004. doi: 10.1016/j.clinsp.2021.100004. eCollection 2022.
COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China.中国武汉以外地区 13 例新型冠状病毒感染的流行病学和临床特征。
JAMA. 2020 Mar 17;323(11):1092-1093. doi: 10.1001/jama.2020.1623.
6
Potential of large "first generation" human-to-human transmission of 2019-nCoV.2019-nCoV 人际间“初代传播”的巨大潜力。
J Med Virol. 2020 Apr;92(4):448-454. doi: 10.1002/jmv.25693. Epub 2020 Feb 14.
7
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.铁螯合疗法的管理:来自全国地中海贫血患者登记处的初步数据。
Anemia. 2011;2011:435683. doi: 10.1155/2011/435683. Epub 2011 Jun 5.
10
[Flowcharts for the diagnosis and the molecular characterization of hemoglobinopathies].[血红蛋白病的诊断和分子特征流程图]
Ann Biol Clin (Paris). 2010 Jul-Aug;68(4):455-64. doi: 10.1684/abc.2010.0457.